Cancerous Axillary Lymph Node Ultrasound: What to Expect

An axillary lymph node ultrasound is a painless imaging exam that uses high-frequency sound waves to evaluate the lymph nodes in your armpit, most often as part of breast cancer staging. The scan itself typically takes around fifteen to thirty minutes, involves no radiation, and requires no special preparation beyond wearing a top that’s easy to remove. What your radiologist is really doing during those quiet minutes is studying each node’s shape, internal structure, and blood flow for a set of specific features that distinguish a healthy node from one harboring cancer cells. Understanding what those features are, how accurately ultrasound detects them, and what happens next if something looks abnormal can take a lot of the uncertainty out of the experience.

How the Exam Is Performed

You’ll lie on your back with the arm on the side being examined raised and rotated outward, which opens up the armpit so the probe can reach all the tissue. Sometimes a small pillow is placed under your shoulder blade to lift the armpit off the table, giving better access to the deeper nodes near the back of the space. The sonographer uses a linear probe operating at a high frequency, which delivers sharp images of structures close to the skin surface. In people with a larger body habitus or a thick layer of axillary fat, the sonographer may switch to a lower-frequency setting to see deeper planes more clearly. The probe is moved methodically from the front edge of the chest muscle to the back edge of the latissimus dorsi muscle, covering the entire axillary space.

1PubMed Central. Ultrasound imaging of the axilla

Most people feel only light pressure and the coolness of the gel. There’s no injection, no contrast agent, and nothing enters your body. If the radiologist spots a node that warrants closer evaluation, they may spend extra time on it with Doppler mode, which maps blood flow within and around the node in color. That portion of the exam looks and feels the same to you but gives the radiologist additional information about whether the node’s blood supply follows a normal or suspicious pattern.

What a Normal Lymph Node Looks Like

On ultrasound, a healthy axillary lymph node has a distinctive appearance: it’s oval, has crisp borders, and contains a bright central stripe called the fatty hilum, which is essentially the node’s internal scaffolding of fat and blood vessels. Surrounding that bright center is a thin, dark outer rim called the cortex, where immune cells live. In a normal node, the cortex measures roughly two to three millimeters thick, depending on which guidelines your institution follows.

2PubMed Central. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality

That bright hilum is actually one of the most reassuring signs a radiologist can see. When it’s present, clearly visible, and running through the center of the node, it suggests the node’s internal architecture is intact and not being replaced by tumor. Size alone isn’t a reliable giveaway. Several studies have found no strong relationship between how large a node is and whether it’s malignant. Small nodes can harbor cancer cells, and large nodes can simply be reactive, meaning your immune system has enlarged them in response to infection, inflammation, or even a recent vaccination.

3American Journal of Sonography. Value of Ultrasound in Evaluation of Abnormal Axillary Lymph Node

Features That Raise Suspicion

When cancer cells travel to a lymph node, they typically seed the outer cortex first and gradually displace the fatty hilum. This progression creates a set of visible changes that radiologists look for systematically:

  • Cortical thickening: The dark outer rim grows beyond three millimeters. It can thicken evenly around the entire node (diffuse thickening) or bulge in one spot (focal thickening). A cortex at or above three millimeters was found to be present in about 83% of nodes with confirmed metastasis versus roughly 23% of benign nodes in one study.
    • 4Nature. Multiparametric ultrasound assessment of axillary lymph nodes in patients with breast cancer
  • Hilum loss: The bright center narrows, becomes eccentric, or disappears entirely, leaving the node looking uniformly dark. Complete hilum absence is the most specific marker of metastatic disease, though it tends to appear only in more advanced spread.
    • 3American Journal of Sonography. Value of Ultrasound in Evaluation of Abnormal Axillary Lymph Node
  • Round shape: Normal nodes are elongated. When tumor replaces the interior, the node tends to become rounder, approaching a 1:1 ratio between its long and short axes.
  • Irregular margins: Blurry or jagged borders can indicate that cancer cells have breached the node’s capsule and are growing into surrounding fat.

One study found that diffuse cortical thickening and complete loss of normal internal texture were the only ultrasound features that independently predicted malignancy in nodes where no breast abnormality had yet been detected on imaging.

5PubMed. Suspicious axillary lymph nodes in patients with unremarkable imaging of the breast

What Doppler Adds to the Picture

Normal lymph nodes receive their blood supply through the hilum, so blood flow appears centrally on a Doppler scan. Cancerous nodes often develop new, disorganized blood vessels around their edges, shifting the flow pattern from central to peripheral. In a study comparing benign and malignant axillary nodes, peripheral flow was seen in about 77% of malignant nodes versus only 28% of benign ones.

6PubMed. Patients with breast cancer: differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes

Another study confirmed this directional shift but with more overlap between groups: about half of the confirmed malignant nodes still showed central blood flow. The takeaway is that Doppler alone isn’t definitive. It improves the radiologist’s confidence when combined with the shape and cortex changes described above, but it doesn’t replace them.

7PubMed Central. Diagnostic Efficacy of Ultrasonography, Doppler Ultrasonography and Elastography in the Evaluation of Suspected Malignant Lymph Nodes

How Accurate Is the Ultrasound Itself

Axillary ultrasound is genuinely useful for ruling in cancer, but it misses a meaningful number of involved nodes. A systematic review of multiple studies reported that when radiologists used morphologic criteria (cortex, hilum, shape), specificity reached as high as 98% but sensitivity ranged from about 26% to 76%. That wide sensitivity range means a normal-looking node on ultrasound doesn’t guarantee it’s clear.

8PubMed. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review

Individual institutional studies broadly agree with those figures. One found a sensitivity of about 63% and a specificity of roughly 85% when comparing preoperative ultrasound to what surgeons found during the operation.

9PubMed Central. Diagnostic Accuracy of Axillary Ultrasonography Compared with Intra-operative Pathological Findings in Patients with Breast Cancer

In practical terms, this means ultrasound is good at identifying nodes that are clearly suspicious, but it cannot confidently declare the armpit cancer-free on its own. That’s why a negative ultrasound in a breast cancer patient is almost always followed by a sentinel lymph node biopsy during surgery, where a dye or radioactive tracer identifies the first node receiving drainage from the tumor and a pathologist examines it under a microscope.

When a Biopsy Follows the Scan

If the ultrasound reveals a suspicious-looking node, your radiologist will usually recommend a needle biopsy before any surgery takes place. This is done while you’re still lying down, using the ultrasound probe to guide the needle in real time. You’ll receive a local anesthetic, so the procedure is uncomfortable more than painful. It typically takes ten to fifteen minutes.

Two needle types are common. Fine-needle aspiration (FNA) uses a thin needle to suction out a small cluster of cells. Core needle biopsy (CNB) uses a slightly larger spring-loaded needle that removes a tiny cylinder of tissue. A large meta-analysis found that FNA had an overall sensitivity of about 79% and specificity of about 96%, while CNB had a sensitivity of roughly 85% and specificity of about 93%.

10Frontiers in Oncology. The accuracy of ultrasound-guided fine-needle aspiration and core needle biopsy in diagnosing axillary lymph nodes in women with breast cancer: a systematic review and meta-analysis

In head-to-head comparisons, core biopsy tends to catch a few more positive cases. One study of 70 patients with confirmed node metastases found FNA detected cancer in about 79% while core detected it in about 87%.

11PubMed Central. Ultrasound Guided Core Biopsy versus Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy in Patients with Breast Cancer

Core biopsy also had a particularly large advantage in nodes classified as high-risk on ultrasound, where it provided a usable diagnostic sample more than twice as often as FNA.

12Journal of Global Oncology. Core Biopsy and FNA: A Comparison of Diagnostic Yield in Lymph Nodes of Different Ultrasound Determined Malignant Potential

The choice between the two depends on institutional preference and the clinical scenario. Both are considered safe, and serious complications are rare when the procedure is performed under ultrasound guidance by an experienced operator.

13PubMed. US-guided core needle biopsy of axillary lymph nodes in patients with breast cancer: why and how to do it

How the Results Affect Your Surgery

The whole point of ultrasound-guided axillary staging before surgery is to help your surgical team choose the least invasive approach that’s still oncologically safe. If the ultrasound looks normal and any biopsy comes back negative, you’ll most likely undergo a sentinel lymph node biopsy at the time of your breast surgery, which removes only one to three nodes and carries a low risk of long-term arm swelling. If the ultrasound and biopsy confirm cancer in the node, the team may recommend removing a larger number of nodes in a procedure called axillary lymph node dissection, which provides more thorough staging but comes with higher rates of lymphedema, numbness, and other complications.

14Egyptian Journal of Radiology and Nuclear Medicine. Correlation between the axillary lymph node status in the pre-operative axillary ultrasound and the surgical outcomes in sentinel lymph node biopsy (SLNB) and axillary lymph node dissection (ALND) in breast cancer patients

One study found that pretreatment axillary ultrasound with core biopsy allowed about a third of patients who would have otherwise undergone sentinel node biopsy to skip it entirely, because cancer was confirmed on needle biopsy and they went straight to more definitive surgery. The same approach also enabled more immediate breast reconstructions, because surgical planning could be finalized before the operating room.

15European Journal of Radiology. Pretreatment axillary ultrasonography and core biopsy in patients with suspected breast cancer: Diagnostic accuracy and impact on management

Monitoring Lymph Nodes During Chemotherapy

If you receive chemotherapy before surgery (called neoadjuvant chemotherapy), your team may use repeat ultrasounds to track how the axillary nodes are responding. Features they look for include shrinkage of the node’s short diameter by half or more, thinning of a previously thickened cortex, and return of the fatty hilum. A study of clinical node-positive patients found that changes in cortical thickness, hilum status, and reduction in short diameter were all independent predictors of whether the cancer in the nodes had been completely eliminated by treatment.

16PubMed Central. Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patients

Ultrasound after chemotherapy is very good at confirming when nodes still look abnormal (high specificity, around 94% in one study) but not as reliable at catching residual microscopic disease in nodes that appear to have normalized. That same study reported a sensitivity of only about 29%, meaning most nodes with leftover cancer looked clean on ultrasound.

17Surgery, Gastroenterology and Oncology. Evaluating Axillary Ultrasound Performance in Post-Neoadjuvant Breast Cancer: A Histopathological Validation Study

This is why ultrasound alone doesn’t determine whether surgery can be scaled back after chemo. It’s combined with clinical exam, sometimes MRI, and ultimately surgical pathology to make that decision.

18PubMed. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients

Signs of Cancer Growing Beyond the Node

Radiologists also look for clues that cancer hasn’t just settled inside a lymph node but has broken through its outer capsule, a situation called extranodal extension. This matters because it can change both your staging and your treatment recommendations. Ultrasound features associated with extranodal extension include nodes that appear matted together (clumped, as if stuck to each other), swelling of the fat immediately surrounding the node, and blurred or indistinct margins.

In a review of over 130 patients, matting and unclear margins were the two features independently associated with extranodal extension. Matting had a specificity of 84%, meaning when nodes looked clumped, they usually truly had cancer growing beyond the capsule. However, the sensitivity for any single feature was modest, so the absence of these signs doesn’t rule out extranodal extension.

19PubMed. Predictive value of sonographic features of extranodal extension in axillary lymph nodes

The Vaccination Pitfall

One scenario that causes real anxiety is having an axillary ultrasound shortly after a vaccination in the same arm. COVID-19 vaccines in particular became well known for causing temporary lymph node swelling on the injected side. Reactive nodes from vaccination can look worrisomely large and show a thickened cortex, mimicking the appearance of early metastatic disease.

20PubMed Central. Axillary adenopathy after COVID-19 vaccine in patients undergoing breast ultrasound

If you’ve had a recent vaccination, mention it before the scan. Many institutions now ask about vaccination timing as part of their standard intake. Depending on the clinical context, the radiologist may recommend a short-interval follow-up scan rather than an immediate biopsy, or they may proceed with biopsy if you already have a known cancer diagnosis and staging can’t wait. The swelling from vaccination typically resolves within a few weeks, while metastatic nodes don’t shrink on their own.

Elastography and Other Newer Techniques

Standard ultrasound evaluates a node’s shape, architecture, and blood flow. A newer add-on called elastography measures tissue stiffness. Cancer cells tend to make tissue stiffer than normal lymphoid tissue, so a node that resists compression may be more suspicious. Two main varieties exist: strain elastography, where the sonographer presses the probe and the software measures how much the tissue deforms, and shear-wave elastography, where the machine generates its own tiny vibration and measures the speed at which the wave travels through the tissue.

Shear-wave elastography has shown that metastatic lymph nodes have significantly higher stiffness values than benign ones, and adding this measurement to standard ultrasound criteria improves the overall ability to separate the two groups.

21PubMed Central. Shear-wave elastography as a supplementary tool for axillary staging in patients undergoing breast cancer diagnosis

Strain elastography studies have reported high sensitivity as well, with one finding that a strain ratio cutoff of 2.1 achieved 100% sensitivity and 67% specificity for identifying metastatic nodes.

22AL-Kindy College Medical Journal. The Role of Strain Elastography in Evaluating Borderline Axillary Lymph nodes

One multiparametric study combined cortical thickness, capsule regularity, and shear-wave stiffness into a single assessment and achieved a sensitivity of 90% and specificity of 75%, better than any single criterion alone.

4Nature. Multiparametric ultrasound assessment of axillary lymph nodes in patients with breast cancer

Elastography is not yet a standard part of every axillary ultrasound, but it’s increasingly available at academic centers and high-volume breast imaging practices, and it’s particularly useful for borderline-looking nodes where the conventional features aren’t clearly normal or clearly suspicious.

Artificial Intelligence in Axillary Ultrasound

Researchers are actively training computer algorithms to analyze ultrasound images of axillary nodes, aiming to improve consistency and catch cases that human eyes might miss. Deep learning models trained on hundreds of ultrasound images have shown promising early results. One model that used ultrasound images of the primary breast tumor to predict axillary node status achieved perfect specificity in a validation set, meaning every node it flagged as metastatic truly was, though the study was small.

23PubMed Central. Artificial intelligence assisted ultrasound for the non-invasive prediction of axillary lymph node metastasis in breast cancer

A separate algorithm trained directly on ultrasound images of the nodes themselves reached an accuracy of about 73%, with sensitivity and specificity figures broadly comparable to what human radiologists achieve.

24Computers in Biology and Medicine. Deep learning prediction of axillary lymph node status using ultrasound images

Another deep learning radiomics model showed high sensitivity for identifying both sentinel and non-sentinel node metastases and was able to stratify patients into risk groups that could help avoid unnecessary extensive surgery.

25PubMed Central. The Role of AI in Breast Cancer Lymph Node Classification: A Comprehensive Review

None of these AI tools have replaced a radiologist’s eye in routine clinical practice yet. The studies so far are retrospective, meaning they analyze images that were already collected rather than prospectively guiding patient care. But the direction of travel is clear. Given the relatively low cost of ultrasound compared to MRI or PET scans, adding a computerized second opinion to the standard exam could eventually make axillary staging more accessible and more accurate, particularly in settings where subspecialty radiologists aren’t readily available.

Standardized Scoring Systems

You may hear a radiologist refer to scoring categories when describing your lymph nodes. One system that has emerged is the Lymph Node Reporting and Data System, or LN-RADS, which assigns each node a score from 1 (normal) through 5 (definitely malignant), with intermediate categories for fatty, reactive, and variably suspicious nodes.

26PubMed Central. Lymph Node Reporting and Data System (LN-RADS)-Retrospective Evaluation for Ultrasound Classification of Superficial Lymph Nodes

Other institutions use their own morphology-based classification schemes. One approach groups nodes into mass-like (no recognizable hilum, looking more like a solid lump than a node), focal cortical thickening, and diffuse cortical thickening, each with different likelihoods of harboring cancer.

27PubMed. Redefining ultrasound appearance criteria of positive axillary lymph nodes

The value of these systems is that they give your care team a shared language and a consistent framework for deciding which nodes warrant biopsy and which can be monitored. If your report mentions a score or a category, ask your radiologist or surgeon what the next step is for that specific tier. The management recommendation depends heavily on your clinical context, particularly whether you already have a known breast cancer diagnosis, what its biology is, and whether chemotherapy is part of the plan.